Signit Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 31 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.84 M
About Signit Laboratories
Signit Laboratories Pvt Ltd (SLPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 1994 and has a history of 31 years. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.84 M.
Gulzar Ahmed and Mehraj War serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U14232PB1994PTC014204
-
Company No.
014204
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Signit Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulzar Ahmed
|
Whole-Time Director | 26-Sep-1994 | Current |
|
Mehraj War
|
Director | 31-May-2008 | Current |
Financial Performance of Signit Laboratories.
Signit Laboratories Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Signit Laboratories?
In 2017, Signit Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.84 M
₹0
Charges Breakdown by Lending Institutions
- The Jammu & Kashmir Bank Limited : 0.16 Cr
- Hdfc Bank Limited : 0.10 Cr
- Jammu And Kashmir Bank Limited : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 May 2024 | Hdfc Bank Limited | ₹1.01 M | Open |
| 12 Feb 2003 | Jammu And Kashmir Bank Limited | ₹0.23 M | Open |
| 20 Apr 1999 | The Jammu & Kashmir Bank Limited | ₹1.60 M | Open |
How Many Employees Work at Signit Laboratories?
Unlock and access historical data on people associated with Signit Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Signit Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Signit Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
